Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8
- 12 June 2000
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (12) , 2385-2394
- https://doi.org/10.1200/jco.2000.18.12.2385
Abstract
PURPOSE: This phase III study was performed to determine the superiority of doxorubicin (DOX) and vinorelbine (VNB) (arm 1) versus DOX alone (arm 2) in metastatic breast cancer (MBC) for overall su...Keywords
This publication has 32 references indexed in Scilit:
- Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast CancerJournal of Clinical Oncology, 1999
- Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.Journal of Clinical Oncology, 1994
- Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimensBritish Journal of Cancer, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of lifeEuropean Journal Of Cancer, 1992
- Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast CancerNew England Journal of Medicine, 1991
- Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1991
- The effect on survival of initial chemotherapy in advanced breast cancer: polychemotherapy versus single drug.Journal of Clinical Oncology, 1987
- A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinomaBritish Journal of Cancer, 1987
- Randomized clinical trial of doxorubicin alone or combined with mitolactol in women with advanced breast cancer and prior chemotherapy exposureAmerican Journal of Clinical Oncology, 1985